A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (INTEGRATEIIa)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02773524 |
|
Recruitment Status :
Recruiting
First Posted : May 16, 2016
Last Update Posted : May 7, 2021
|
Sponsor:
Australasian Gastro-Intestinal Trials Group
Collaborators:
Canadian Cancer Trials Group
Academic and Community Cancer Research United
National Health and Medical Research Council, Australia
Information provided by (Responsible Party):
Australasian Gastro-Intestinal Trials Group
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 2022 |
| Estimated Study Completion Date : | December 2022 |